Litcius/Paper detail

Exosomes with FOXP3 from gene-modified dendritic cells ameliorate the development of EAE by regulating the balance of Th/Treg

Zhen Jia, Jia Liu, Bin Li, Yi Le, Yanmin Wu, Jun-Na Xing, Liang Wang, Jinli Wang, Li Guo

2022International Journal of Medical Sciences14 citationsDOIOpen Access PDF

Abstract

To investigate the efficiency and potential mechanisms of exosomes from dendritic cells (DCs) transfected with Forkhead box protein P3 (FOXP3) in the development of experimental autoimmune encephalomyelitis (EAE). Method: Mouse bone marrow-derived immature DCs were loaded with adenovirus carrying FOXP3 gene, and exosomes were generated. Then the exosomes with FOXP3 (FOXP3-EXOs) were co-cultured with CD4+T cell in vitro to evaluate their potential on CD4+T cell proliferation and differentiation, and injected into EAE mice to assess their effects on the development of EAE. Result: FOXP3-EXOs were effective to inhibit the CD4 + T cell proliferation and the production of Interferon gamma (IFN-), interleukin (IL)-6, and IL-17, while they promoted the production of IL-10 in vitro. Moreover, FOXP3-EXOs treatment significantly decreased the neurological scores, reduced the infiltration of inflammatory cells into the spinal cord, and decreased demyelination in comparison to saline and Con-EXOs treated EAE mice. Moreover, the FOXP3-EXOs treatment resulted in obvious increases in the levels of regulatory T (Treg) cells and IL-10, whereas levels of T helper 1 (Th1) cells, Th17 cells, IFN-, IL-6, and IL-17 decreased significantly in the splenocyte culture of EAE mice.

Topics & Concepts

FOXP3Experimental autoimmune encephalomyelitisImmunologyInterleukin 17MicrovesiclesRAR-related orphan receptor gammaChemistryCell biologyCancer researchBiologyCytokineImmune systemmicroRNAGeneBiochemistryExtracellular vesicles in diseaseImmunotherapy and Immune ResponsesInflammasome and immune disorders